What Is the Donut Hole?
The donut hole is a coverage gap in Medicare Part D drug plans where your out-of-pocket costs jump sharply after you and your plan spend a combined $5,850 in 2024. Once you hit this threshold, you pay 25% of brand-name drug costs and 25% of generic drug costs until your total out-of-pocket spending reaches $8,550 (also 2024 figures). After that point, you enter catastrophic coverage where Medicare covers 80% of costs.
How the Donut Hole Affects Your Claims and Appeals
The donut hole creates a specific problem when reviewing denials on your Explanation of Benefits (EOB). Insurers sometimes deny medications during the donut hole phase by claiming they lack "medical necessity," when the real issue is coverage tier rules or prior authorization requirements tied to donut hole thresholds. Request your plan's current coverage limits and deductible status before appealing. Your internal appeal must reference your plan's specific cost-sharing structure for your drug class to challenge the denial effectively.
If your insurer denies a medication you need during donut hole coverage, file an internal appeal within 60 days citing the specific dollar amounts from your EOB. Include your cumulative out-of-pocket costs to prove you're in the donut hole phase. Some state insurance regulators, particularly in California and New York, have ruled that plans cannot arbitrarily deny drugs based solely on donut hole status without documented medical contraindications. An external appeal to your state's insurance commissioner can override the denial if your plan failed to follow state regulations.
Key Facts About the Donut Hole
- The combined spending threshold triggers the donut hole, not just your personal spending. This includes what your plan has already paid.
- The donut hole ends when you reach $8,550 out-of-pocket in 2024, adjusting annually for inflation.
- Manufacturer copay assistance programs count toward your out-of-pocket costs, which can help you exit the donut hole faster.
- Your EOB should clearly show which phase you're in, but errors are common. Request an itemized statement of accumulated costs from your plan if you dispute the donut hole calculation.
- Prior authorization denials during donut hole phases often hide coverage gap issues. Request the specific medical policy the plan cited to deny the drug, then appeal with your doctor's medical records showing why that policy doesn't apply.
- Plans must apply manufacturer rebates during the donut hole, though the calculation method varies by plan type. Ask your plan administrator how rebates affect your out-of-pocket total.
Common Questions
- Can my plan deny a drug just because I'm in the donut hole? No. A denial must cite medical policy, prior authorization requirements, or formulary status, not simply the donut hole phase. If the denial letter only references cost-sharing amounts without medical justification, cite this lack of reasoning in your internal appeal as grounds for reversal.
- Does the donut hole affect my right to appeal? No. Your appeal rights remain identical regardless of which coverage phase you're in. You have 60 days for internal appeals and can request external review if the plan denies your internal appeal.
- How do I know if my plan's donut hole calculation is correct? Request a detailed statement of all covered and paid claims year-to-date. Verify that only eligible drug purchases count toward your out-of-pocket total, not copays for other services. Some plans incorrectly include plan-paid amounts in your benefit-received totals.
Related Concepts
- Medicare Part D - The prescription drug coverage program where the donut hole applies.
- Catastrophic Coverage - The final phase after you exit the donut hole, where Medicare covers 80% of costs.